ライフサイエンスコーパス: hypnotics

1 sychotics, antidepressants, anxiolytics, and hypnotics.

2 ects of neurobiological response to sedative-hypnotics.

3 icidal" with each of the modern FDA-approved hypnotics.

4 re anxiety that was unresponsive to sedative hypnotics.

5 n and need for constant infusion of sedative-hypnotics.

6 easing the use of antipsychotics or sedative-hypnotics.

7 e sedation and serve as targets for sedative hypnotics.

8 the majority of clinically relevant sedative-hypnotics.

9 er flies, and is modulated by stimulants and hypnotics.

10 idely used anxiolytics, anticonvulsants, and hypnotics.

11 used as anxiolytics, and for short-half-life hypnotics (all zopiclone).

12 was to estimate the risk of repeated use of hypnotics among individuals with celiac disease as a pro

13 trical activity) of intact resting muscle by hypnotics, analgesia is required to prevent pain-evoked

14 variety of behavioral responses to sedative-hypnotics and may directly facilitate progress in human

15 icularly addressing the fields of sedatives, hypnotics and neuromuscular blockers, however, there is

16 Regional anesthesia, as well as hypnotics and opioids, promotes intraoperative muscle re

17 Despite widespread use of standard hypnotics and sedating antidepressants for chronic insom

18 For the induction dose of hypnotics and the initial dose of other drugs that have

19 dosages of antidepressants, antipsychotics, hypnotics, and antidementia medications were allowed.

20 re antidepressants, antipsychotics, sedative-hypnotics, and antidepressant-antipsychotic combinations

21 tonin reuptake inhibitors, nonbenzodiazepine hypnotics, and antihistamines for more than 4 weeks was

22 y alcohol, marijuana or cocaine, anesthetics/hypnotics, and oral opioids.

23 Epidemiological studies show that hypnotics are associated with an increased risk for suic

24 This review focused on modern, FDA-approved hypnotics, beginning with the introduction of benzodiaze

25 This review focused on modern, FDA-approved hypnotics, beginning with the introduction of benzodiaze

26 of using benzodiazepines, nonbenzodiazepine hypnotics, beta-blockers, selective serotonin reuptake i

27 cern is that benzodiazepine receptor agonist hypnotics can cause parasomnias, which in rare cases may

28 , 1.87; 95% CI, 1.70-2.06), receive sedative hypnotics concurrently (40.7% vs 7.6%, adjusted RR, 5.46

29 rivation, and can be induced by conventional hypnotics, diazepam and sodium pentobarbital.

30 ta, USA) and novel 'soft-drug' sedatives and hypnotics (e.g. CNS-7259X and TD-4756) as well as a nove

31 observational studies suggested that use of hypnotics for insomnia was associated with increased ris

32 its, including diverse responses to sedative-hypnotics, have been detected on distal chromosome 1 in

33 icity from accentuated responses to sedative hypnotics in active cocaine-abusing subjects.

34 ing evidence-based guidelines for the use of hypnotics in the management of chronic insomnia.

35 the evidence for and against the claim that hypnotics increase the risk of suicide.

36 s anxiolytics, anticonvulsants, and sedative/hypnotics is limited by rapid metabolism.

37 Evidence for benzodiazepine hypnotics, melatonin agonists, and antidepressants, and

38 tween DAAs and antidepressants, anxiolytics, hypnotics, mood stabilizers, antipsychotics and treatmen

39 Patients may use sedatives, hypnotics, or alcohol in an effort to interrupt this pro

40 tion (TV) and exposure to opioids, sedatives-hypnotics, or general anaesthetics in neonates (O-SH-GA)

41 analgesics (HR, 1.22; 95% CI, 1.08 to 1.37), hypnotics/sedatives (HR, 1.21; 95% CI, 1.07 to 1.37), an

42 analgesics (HR, 1.33; 95% CI, 1.16 to 1.52), hypnotics/sedatives (HR, 1.24; 95% CI, 1.07 to 1.43), GI

43 There is no association between hypnotics, such as zopiclone, and sleep outcomes, alertn

44 r sleep was defined as >/=2 prescriptions of hypnotics using prospective data from the National Presc

45 n which neither antidepressants nor sedative/hypnotics were prescribed.

46 ly in elderly patients taking benzodiazepine hypnotics, who comprise a large proportion of the depend

47 99% CI, 6.77-35.31); and 2 or more sedative-hypnotics, with anxiety disorders (OR, 2.13; 99% CI, 1.4

48 from pentobarbital as well as other sedative-hypnotics (zolpidem and ethanol) versus wild-type litter